ROCKWELL MEDICAL, INC. Increase (Decrease) in Accounts Receivable
ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Accounts Receivable of -$288.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$970.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $682.00K, a 50.54% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $61.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $244.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2025 was $98.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$2.61M, a 156.23% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2023 was $4.64M, a 1241.62% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2022 was $346.00K, a 80.14% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$288.00K 10-Q · filed 2026-08-13 | -$227.00K derived: sum of 3 quarters · filed 2026-08-13 | $17.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $682.00K 10-Q · filed 2026-05-07 | $743.00K derived: sum of 2 quarters · filed 2026-05-07 | $987.00K derived: sum of 3 quarters · filed 2026-05-07 | -$599.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $305.00K derived: sum of 2 quarters · filed 2026-03-26 | -$1.28M derived: sum of 3 quarters · filed 2026-08-13 | $98.00K 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.34M derived: sum of 2 quarters · filed 2026-08-13 | $37.00K 10-Q · filed 2025-11-12 | -$549.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$207.00K 10-Q · filed 2026-08-13 | -$793.00K derived: sum of 3 quarters · filed 2026-08-13 | -$2.76M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.38M 10-Q · filed 2026-05-07 | $793.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.17M derived: sum of 3 quarters · filed 2026-05-07 | -$1.42M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$2.55M derived: sum of 2 quarters · filed 2026-03-26 | -$2.80M derived: sum of 3 quarters · filed 2026-03-26 | -$2.61M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.22M derived: sum of 2 quarters · filed 2025-11-12 | -$2.02M 10-Q · filed 2025-11-12 | -$484.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$61.00K 10-Q · filed 2025-08-14 | $1.48M derived: sum of 3 quarters · filed 2025-08-14 | $5.43M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $193.00K 10-Q · filed 2025-05-12 | $1.73M derived: sum of 2 quarters · filed 2025-05-12 | $5.68M derived: sum of 3 quarters · filed 2025-05-12 | $5.07M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $5.49M derived: sum of 2 quarters · filed 2025-03-20 | $4.88M derived: sum of 3 quarters · filed 2025-03-20 | $4.64M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.34M derived: sum of 2 quarters · filed 2024-11-12 | $3.10M 10-Q · filed 2024-11-12 | $1.99M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$848.00K 10-Q · filed 2024-08-08 | -$1.96M derived: sum of 3 quarters · filed 2024-08-08 | -$2.68M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$238.00K 10-Q · filed 2024-05-14 | -$1.35M derived: sum of 2 quarters · filed 2024-05-14 | -$2.07M derived: sum of 3 quarters · filed 2024-05-14 | -$1.10M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$1.83M derived: sum of 2 quarters · filed 2024-03-21 | -$862.00K derived: sum of 3 quarters · filed 2024-03-21 | $346.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$723.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $246.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.45M 10-Q · filed 2023-11-14 | $1.33M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $969.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.18M 10-Q · filed 2023-08-14 | $2.05M derived: sum of 3 quarters · filed 2023-08-14 | $2.73M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-15 | $1.08M derived: sum of 2 quarters · filed 2023-05-15 | $1.76M derived: sum of 3 quarters · filed 2023-05-15 | $524.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $556.00K derived: sum of 2 quarters · filed 2023-03-30 | -$684.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.74M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$561.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.86M 10-Q · filed 2022-11-14 | $1.91M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.19M 10-Q · filed 2022-08-15 | $1.23M derived: sum of 3 quarters · filed 2022-08-15 | $1.79M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $2.43M 10-Q · filed 2022-05-16 | $2.47M derived: sum of 2 quarters · filed 2022-05-16 | $3.03M derived: sum of 3 quarters · filed 2022-05-16 | $2.01M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $605.00K derived: sum of 2 quarters · filed 2022-04-08 | -$416.00K derived: sum of 3 quarters · filed 2022-04-08 | -$32.00K 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $563.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$458.00K derived: sum of 2 quarters · filed 2021-11-15 | -$74.00K 10-Q · filed 2021-11-15 | -$994.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$637.00K 10-Q · filed 2021-08-16 | -$637.43K 10-Q · filed 2020-08-10 | -$1.56M derived: sum of 3 quarters · filed 2021-08-16 | -$1.82M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $384.00K 10-Q · filed 2021-05-17 | $384.02K 10-Q · filed 2020-05-11 | -$536.00K derived: sum of 2 quarters · filed 2021-05-17 | -$802.34K derived: sum of 3 quarters · filed 2021-05-17 | -$2.12M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$920.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$1.19M derived: sum of 2 quarters · filed 2021-03-31 | -$2.51M derived: sum of 3 quarters · filed 2021-03-31 | -$2.78M 10-K · filed 2021-03-31 | -$2.78M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | -$266.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.59M derived: sum of 2 quarters · filed 2020-11-09 | -$1.86M 10-Q · filed 2020-11-09 | -$1.86M 10-Q · filed 2019-11-12 | -$2.46M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.59M 10-Q · filed 2020-08-10 | -$2.19M derived: sum of 3 quarters · filed 2020-08-10 | $34.45K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$268.10K 10-Q · filed 2020-05-11 | -$870.29K derived: sum of 2 quarters · filed 2020-05-11 | $1.36M derived: sum of 3 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | -$602.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $1.63M derived: sum of 2 quarters · filed 2020-03-17 | $623.95K 10-K · filed 2020-03-17 | |||||
| 2018-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.23M 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$1.00M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |